These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 983859)

  • 1. Gastric secretory and motor inhibition induced by certain methyl analogues of prostaglandin E2 in healthy male volunteers and in patients with duodenal ulcer disease.
    Nylander B; Andersson S
    Adv Prostaglandin Thromboxane Res; 1976; 2():521-8. PubMed ID: 983859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.
    Robert A; Schultz JR; Nezamis JE; Lancaster C
    Gastroenterology; 1976 Mar; 70(3):359-70. PubMed ID: 174967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effects of prostaglandins and H2-receptor antagonists on gastric acid secretion, mucosal blood flow and ulcer formation.
    Banerjee AK; Christmas AJ; Hall CE
    Arzneimittelforschung; 1979; 29(4):634-9. PubMed ID: 39581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two methylated prostaglandin E2 analogs on gastroduodenal pressure in man.
    Nylander B; Andersson S
    Scand J Gastroenterol; 1975; 10(1):91-5. PubMed ID: 1124344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric secretory inhibition by two 16-methylated analogs of prostaglandin E2 given intragastrically to patients with duodenal ulcer disease.
    Nylander B; Andersson S
    Scand J Gastroenterol; 1975; 10(2):217-20. PubMed ID: 1091967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients.
    Ippoliti AF; Isenberg JI; Hagie L
    Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients.
    Ippoliti AF; Isenberg JI; Maxwell V; Walsh JH
    Gastroenterology; 1976 Apr; 70(4):488-91. PubMed ID: 1254135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man.
    Konturek SJ; Kwiecień N; Swierczek J; Oleksy J; Sito E; Robert A
    Gastroenterology; 1976 May; 70(5 PT.1):683-7. PubMed ID: 770226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cholecystokinin and 16,16-dimethyl prostaglandin E2 on RNA and DNA of gastric and duodenal mucosa.
    Johnson LR; Guthrie P
    Gastroenterology; 1976 Jan; 70(1):59-65. PubMed ID: 1245285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an orally administered prostaglandin analogue (16, 16-dimethyl prostaglandin E2) on human gastric secretion.
    Wilson DE; Winnan G; Quertermus J; Tao P
    Gastroenterology; 1975 Sep; 69(3):607-11. PubMed ID: 1158077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of some naturally occurring prostaglandins and synthetic analogues on gastric secretion and ulcer healing in man.
    Karim SM; Fung WP
    Adv Prostaglandin Thromboxane Res; 1976; 2():529-39. PubMed ID: 790914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
    Leitold M; Fleissig W; Merk A
    Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical analysis of the gastric secretory response of patients with duodenal ulcer in dependence of their age and duration of complaints.
    Mózsik G; Venter E; Schmelczer M; Kutas J; Nagy L; Tárnok F
    Acta Med Acad Sci Hung; 1981; 38(2):117-28. PubMed ID: 7324803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interdigestive gastroduodenal motility in duodenal ulcer: role of gastric acid hypersecretion.
    Bortolotti M
    Am J Gastroenterol; 1989 Jan; 84(1):17-21. PubMed ID: 2521420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
    Gaginella TS; Müller RK; Witt CG; Rosen P; Holland GW; Gallo-Torres H; Sullivan AC
    J Pharmacol Exp Ther; 1985 Jan; 232(1):202-7. PubMed ID: 2578188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prostaglandin E2 and 15(R)15 methyl prostaglandin E2 on canine gastric parietal cell: an ultrastructural study.
    Fung WP; Papadimitriou JM
    Am J Gastroenterol; 1979 Nov; 72(5):522-7. PubMed ID: 532795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of misoprostol on histamine-related gastric secretion in man.
    Wilson DE; Wilson PC
    J Assoc Acad Minor Phys; 1989; 1(1):16-8. PubMed ID: 2520847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of flurbiprofen and 16,16-dimethyl prostaglandin E2 on gastrointestinal tumorigenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats: glandular epithelium of stomach and duodenum.
    Lehnert T; Deschner EE; Karmali RA; DeCosse JJ
    Cancer Res; 1990 Jan; 50(2):381-4. PubMed ID: 2295078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioctic acid protection against ethanol-induced gastric mucosal lesions involves sulfhydryl and prostaglandin participation.
    Gutiérrez-Cabano CA
    Acta Gastroenterol Latinoam; 1997; 27(1):31-7. PubMed ID: 9339234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.